Study Shows Poverty Undercuts Otherwise Major Gains In HIV Treatment In a groundbreaking study published last year, scientists reported that effective treatment with HIV medications not only restores health and prolongs life in many HIV-infected patients, but also curtails transmission to sexual partners up to ninety-seven percent. However, a new study by UCSF scientists shows that lack of basic living needs severely undercuts these advances in impoverished men... 30 April 2012

FDA Update Safety Information On HIV Drug Victrelis (Boceprevir) The United States Food and Drug Administration (FDA) is updating information on Victrelis (boceprevir). The drug is used as a hepatitis C (HCV) protease inhibitor. It is combined with various ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitors... 27 April 2012

Breastfeeding For Longer Plus Extended ART May Reduce Mother-To-Child HIV Transmission Long-term results of the Breastfeeding, Antiretrovirals, and Nutrition (BAN) randomized trial reveals that breastfeeding for a longer period along (6+ months) with antiretroviral therapy (ART) could help reduce mother-to-child HIV transmission as well as improve chances of infant's survival... 27 April 2012

Potential For Future Drug Therapy Based On Mechanism Of HIV Spread A new understanding of the initial interactions of human immunodeficiency virus type 1 (HIV-1) and dendritic cells is described by Boston University School of Medicine (BUSM) researchers in a study currently featured in the Proceedings of the National Academy of Sciences (PNAS). With over 2... 25 April 2012

News From The Journal Of Clinical Investigation: April 23, 2012 GENE THERAPY: Inadvertent changes: how engineered viruses disrupt normal gene expression Gene therapy holds the promise of treating genetic conditions by restoring normal gene function. The field has developed slowly over the last several decades with high importance placed on safety to reduce the chance that introduced genes cause problems... 24 April 2012